Does it decay? Obtaining decaying correlation parameter values from previously analysed cluster randomised trials.

Cluster autocorrelation hierarchical models intracluster correlation sample size calculation stepped wedge within-cluster correlation structure

Journal

Statistical methods in medical research
ISSN: 1477-0334
Titre abrégé: Stat Methods Med Res
Pays: England
ID NLM: 9212457

Informations de publication

Date de publication:
Nov 2023
Historique:
medline: 28 11 2023
pubmed: 17 8 2023
entrez: 17 8 2023
Statut: ppublish

Résumé

A frequently applied assumption in the analysis of data from cluster randomised trials is that the outcomes from all participants within a cluster are equally correlated. That is, the intracluster correlation, which describes the degree of dependence between outcomes from participants in the same cluster, is the same for each pair of participants in a cluster. However, recent work has discussed the importance of allowing for this correlation to decay as the time between the measurement of participants in a cluster increases. Incorrect omission of such a decay can lead to under-powered studies, and confidence intervals for estimated treatment effects can be too narrow or too wide, depending on the characteristics of the design. When planning studies, researchers often rely on previously reported analyses of trials to inform their choice of intracluster correlation. However, most reported analyses of clustered data do not incorporate a correlation decay. Thus, often all that is available are estimates of intracluster correlations obtained under the potentially incorrect assumption of no decay. In this article, we show that it is possible to use intracluster correlation values obtained from models that incorrectly omit a decay to inform plausible choices of decaying correlations. Our focus is on intracluster correlation estimates for continuous outcomes obtained by fitting linear mixed models with exchangeable or block-exchangeable correlation structures. We describe how plausible values for decaying correlations may be obtained given these estimated intracluster correlations. An online app is presented that allows users to obtain plausible values of the decay, which can be used at the trial planning stage to assess the sensitivity of sample size and power calculations to decaying correlation structures.

Identifiants

pubmed: 37589088
doi: 10.1177/09622802231194753
pmc: PMC10683336
doi:

Types de publication

Randomized Controlled Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2123-2134

Déclaration de conflit d'intérêts

Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Références

Stat Methods Med Res. 2021 Feb;30(2):612-639
pubmed: 32631142
Clin Trials. 2021 Oct;18(5):529-540
pubmed: 34088230
Stat Med. 2016 Nov 20;35(26):4718-4728
pubmed: 27350420
Contemp Clin Trials. 2007 Feb;28(2):182-91
pubmed: 16829207
Stat Methods Med Res. 2000 Apr;9(2):81-94
pubmed: 10946428
J Clin Epidemiol. 2019 Dec;116:161-166
pubmed: 31272885
Int J Epidemiol. 2020 Jun 1;49(3):979-995
pubmed: 32087011
Stat Methods Med Res. 2019 Mar;28(3):703-716
pubmed: 29027505
Stat Med. 2016 Jun 15;35(13):2149-66
pubmed: 26748662
Int J Epidemiol. 2022 Dec 13;51(6):2000-2013
pubmed: 35679584
Trials. 2016 Aug 15;17:402
pubmed: 27524396
Stat Med. 2020 Mar 4;:
pubmed: 32133688
BMC Med Res Methodol. 2014 Apr 22;14:54
pubmed: 24755392
Clin Trials. 2022 Aug;19(4):353-362
pubmed: 34991379
Stat Med. 2019 May 20;38(11):1918-1934
pubmed: 30663132
Stat Med. 2019 Nov 10;38(25):5021-5033
pubmed: 31475383
Can J Cardiol. 2021 Oct;37(10):1569-1577
pubmed: 34217808
Stat Methods Med Res. 2019 Oct-Nov;28(10-11):3112-3122
pubmed: 30189794

Auteurs

Jessica Kasza (J)

School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.

Rhys Bowden (R)

School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.

Yongdong Ouyang (Y)

Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada.
School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada.

Monica Taljaard (M)

Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada.
School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada.

Andrew B Forbes (AB)

School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH